Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Karisma Pilot
2014-005005-20Phase 2Terminated
- Sponsor
- Karolinska Institutet
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tamoxifen in breast cancer (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Primary: change in mammographic density over time with two tamoxifen doses. Started Dec 2014; status: terminated.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-005005-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005005-20.